V Sahai, MD, MS

Morphomics, Survival, and Metabolites in Patients With Metastatic #PancreaticCancer jamanetwork.com/journals/jaman… This study really drives home the point about evaluating body composition (morphomics) in pancreatic cancer clinical trials.

Overview of the novel autophagy inhibitor PIKfyve presented by Dr. Vaibhav Sahai @VSahaiMD from University of Michigan: targeting cellular processes to combat malignancies! #DAVAGI

@shaib_walid can you send me your email address for the manuscript? Urgent.

#ASCO22 #PancreaticCancer 🤔Is more better❓ ✅Dr. Carrato🧑‍🏫a Rand trial 👉Gem-nab-pac➡️FOLFOX (sequenced Q6 wks) vs. 👉Standard Gem-nab-pac ➡️mOS was 3.5mos⬆️with sequenced Tx ➡️Even though more standard pts got 2nd line Tx 🤯Really❓ 🤔Interesting 🔎GI Can Oral Abst 4022

The $100 genome via @UltimaGenomics techcrunch.com/2022/05/31/ult…

"The 2:1 randomized phase 2 part of the trial... will now determine the efficacy of devimistat at this maximum tolerated dose in combination with gemcitabine and cisplatin as compared with the combination chemotherapy alone,” says #RogelCancer's @VSahaiMD. targetedonc.com/view/devimista…

@BBCWorld The news is missing reference to the scientific publication - important to instill confidence and counter fake news. Covid: Pfizer and AstraZeneca jabs effective against Indian variant - study bbc.co.uk/news/uk-572145…

After 19 years, I’ve left Stanford. The accumulated gender discrimination and harassment had taken their toll. I shared my story with @kate_selig and @StanfordDaily because I think it is important and hope it will empower others to speak up. THREAD 1/ stanforddaily.com/2020/06/10/des…

@drlauragoff @ShaalanBeg @Sahaiz @DocDustyD @utswcancer @curecc @pashtoonkasi @MPishvaian @rachnatshroff Yeah. And the Gem Cis Durva Treme data just seem too good to be true.

Outstanding poster discussion by Dr. Katie Kelley...head spinning gleefully with all of the advancements in hepaobiliary cancers! @UCSFCancer @Sahaiz @rachnatshroff @autumnmcree @ShaalanBeg @DocDustyD @KristenCiombor @CardinMD @RajivAgarwalMD @nanudasmd @VUMC_Cancer

We are all coming to the same conclusion! TNT with predictive marker(s) to allow therapy switching. Our next trial at @uc_health is exactly that...an adaptive design. Ultimately better drugs needed. @SyedAAhmad5 @isteaus @rachnatshroff @BenWestphalen @DrEstfan

@ShaalanBeg @Sahaiz @DocDustyD @utswcancer @curecc @pashtoonkasi @kmody29 @MPishvaian @rachnatshroff I’m a data purist until I’m not😉. Hoping we will find a way to use immunotherapy in #cholangiocarcinoma but we don’t know it yet. That’s why @Sahaiz and his #clinicaltrials are so important!

What is the role of immunotherapy for CHOLANGIOCARCINOMA? @Sahaiz lead a trial of immunotherapy vs chemo-immunotherapy. Chemo-immunotherapy looks good, but did not beat the historical average. There are P3 trials looking at this combination, any predictions?

A new article from #UMichPath faculty Jiaqi Shi, MD, PhD, discusses intraductal papillary neoplasm of the bile duct and its relationship to radiology-pathology. Read the full publication here: clinicalimaging.org/article/S0899-…

@MPishvaian @curecc @ShaalanBeg ORR data pending

7/ #cholangiocarcinoma @curecc @Sahaiz @ShaalanBeg 7) This creates an interesting context to view the updated ORR data for Abs #4582 (Gem-cis-Nivo vs. Ipi-Nivo)

@OncoAlert, here are my Top 10 GI abstracts for #ASCO2020 (w/a bend towards #PancreaticCancer, @PanCAN @letswinpc @lustgartenfdn). @agrothey @pashtoonkasi @GIcancerDoc @kmody29 @EileenMOReilly @ShaalanBeg @drsmags @W_Park_MD @NirajGusani @drallysonocean 1/

We are deeply saddened that faculty member Professor Stephen Schwartz passed away due to a COVID-19 infection. He has left a lasting imprint on our department, our university, and the broader scientific community and will be greatly missed.

Overall survival in patients with pancreatic cancer receiving matched therapies following molecular profiling: a retrospective analysis of the Know Your Tumor registry trial thelancet.com/journals/lanon…

US announces countrywide ban on flavoured e-cigs bbc.com/news/business-…

Work by @Sahaiz and team featured by @TheImagingWire

'U-M Approach Could Improve the Accuracy of Cancer Clinical Trials labblog.uofmhealth.org/health-tech/u-… Who does tumor measurements for clinical trials at your center? @Sahaiz @DavendraSohal @agrothey @hmcarthur @pashtoonkasi @loconte @DrMarkham @tmprowell @montypal @ivpedrosa @DrSGraff